News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pheromone Sciences Corp. Builds Scientific Advisory Board: Sertoli Cell Expert Dr. Jannette Dufour To Help Develop Diabetes Product
August 1, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Pheromone Sciences Corp. ("Pheromone") (TSX VENTURE: PHS) is pleased to announce that Dr. Jannette Dufour, PhD has joined its Scientific Advisory Board ("SAB") to assist the company with its diabetes product development.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody
October 22, 2025
·
1 min read
·
Dan Samorodnitsky
C-suite
Novo Foundation Replaces Pharma’s Board, Revealing Deep Divisions Over Leadership
October 21, 2025
·
4 min read
·
Annalee Armstrong
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
October 21, 2025
·
2 min read
·
Tristan Manalac
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
·
2 min read
·
Tristan Manalac